Circulating β-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients -: Role of oxidative stress

被引:18
|
作者
Pawlak, K
Pawlak, D
Mysliwiec, M
机构
[1] Med Univ Bialystok, Dept Nephrol & Transplantol, PL-15540 Bialystok, Poland
[2] Med Univ Bialystok, Dept Pharmacodynam, PL-15230 Bialystok, Poland
关键词
beta-chemokines; cardiovascular disease; hemodialysis; MMP/TIMP system; oxidative stress;
D O I
10.1016/j.cyto.2004.12.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), beta-chemokines, increased oxidative stress (SOX) and inflammation have been implicated as important factors in atherosclerosis and vascular remodeling. We hypothesized the possible roles of P-chemokines [monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory proteins (MIP-1 alpha, MIP-1 beta) and regulated upon activation, normal T-cell expressed and secreted (RANTES)] as regulators of the metabolism of the vascular extracellular matrix in conditions of increased SOX in hemodialysis (HD) patients. We compared pre-dialysis levels of MMP-9/TIMP-1 system, beta-chemokines, Cu/Zn superoxide dismutase (Cu/Zn SOD) as a marker of SOX and C-reactive protein (CRP) as a marker of inflammation in HD patients with and without cardiovascular disease (CVD) to those of controls. HD patients, particularly those with CVD, showed a significant increase in values of Cu/Zn SOD, CRP, TIMP-1, TIMP-1/MMP-9 ratio, MCP-1 and MIP-1 beta, whereas RANTES levels were lower than in the controls. The levels of MIP-1 alpha as well as MMP-9 in all HD groups were similar to the controls. The positive correlations were observed between the MMP-9/TIMP-1 system and beta-chemokines, SOX and inflammation in whole HD group and in the subgroup with CVD. Multivariate analysis showed that the duration of dialysis followed by Cu/Zn SOD, MIP-1 alpha and beta levels were the significant positive predictors of TIMP-1. In conclusion, our data show that MMP-9/TIMP-1 system and beta-chemokines could cooperate in conditions of elevated SOX, which ultimately predisposes hemodialysis patients to accelerated atherosclerosis. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 50 条
  • [1] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis
    Szamatowicz, J
    Laudanski, P
    Tomaszewska, I
    [J]. HUMAN REPRODUCTION, 2002, 17 (02) : 284 - 288
  • [2] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
    Sunagawa, Shinpei
    Ichiyama, Takashi
    Honda, Rie
    Fukunaga, Shinnosuke
    Maeba, Shinji
    Furukawa, Susumu
    [J]. BRAIN & DEVELOPMENT, 2009, 31 (08): : 588 - 593
  • [3] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [4] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
    Boz, Cavit
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
  • [5] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 617 - 618
  • [6] The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia
    Choi, KH
    Lee, HB
    Jeong, MY
    Rhee, YK
    Chung, MJ
    Kwak, YG
    Lee, YC
    [J]. CHEST, 2002, 121 (05) : 1478 - 1485
  • [7] Validating Sampling Methods for Measurement of Circulating Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1
    Zhang, Ru-Yuan
    Cui, Wei
    Zhao, Kai-Jun
    Tang, Yao-Qing
    Li, Lei
    [J]. PANCREAS, 2010, 39 (06) : 937 - 937
  • [8] Role of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and hyaluronic acid in acute pyelonephritis
    Kavaz, A.
    Ekim, M.
    Ikinciogullari, A.
    Guloglu, D.
    Ozcakar, Z. B.
    Yalcinkaya, F.
    [J]. PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1701 - 1701
  • [9] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [10] The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the growth type of cholangiocarcinoma.
    Park, YN
    Chae, KJ
    Koo, JS
    Oh, BK
    Rha, SY
    Yang, WI
    Choi, JS
    [J]. HEPATOLOGY, 2002, 36 (04) : 397A - 397A